Literature DB >> 11819543

Localization of HCV RNA and capsid protein in human hepatocellular carcinoma.

Yi-Ming Dai, Zhi-Ping Shou, Can-Rong Ni, Neng-Jin Wang, Song-Ping Zhang.   

Abstract

Entities:  

Year:  2000        PMID： 11819543      PMCID： PMC4723583          DOI： 10.3748/wjg.v6.i1.136

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  11 in total

1.  Monoclonal antibodies identify the NS5 yellow fever virus non-structural protein in the nuclei of infected cells.

Authors:  A Buckley; S Gaidamovich; A Turchinskaya; E A Gould
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

2.  Distribution of hepatitis C virus RNA in the liver and its relation to histopathological changes.

Authors:  S Kojima; Y Tanaka; N Enomoto; F Marumo; C Sato
Journal:  Liver       Date:  1996-02

3.  In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma.

Authors:  D Sansonno; V Cornacchiulo; V Racanelli; F Dammacco
Journal:  Cancer       Date:  1997-07-01       Impact factor: 6.860

4.  Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C.

Authors:  P H McGuinness; G A Bishop; D M Painter; R Chan; G W McCaughan
Journal:  Hepatology       Date:  1996-04       Impact factor: 17.425

5.  Detection of hepatitis C virus RNA in liver tissues by an in situ hybridization technique.

Authors:  Y Haruna; N Hayashi; N Hiramatsu; T Takehara; H Hagiwara; Y Sasaki; A Kasahara; H Fusamoto; T Kamada
Journal:  J Hepatol       Date:  1993-04       Impact factor: 25.083

6.  Detection of antigens related to hepatitis C virus RNA encoding the NS5 region in the livers of patients with chronic type C hepatitis.

Authors:  M Tsutsumi; S Urashima; A Takada; T Date; Y Tanaka
Journal:  Hepatology       Date:  1994-02       Impact factor: 17.425

7.  Localization of hepatitis C viral RNA and capsid protein in human liver.

Authors:  G Yamada; H Nishimoto; H Endou; T Doi; M Takahashi; T Tsuji; H Yoshizawa; M Nozawa; T Koji; P K Nakane
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

8.  Expression of hepatitis C virus in hepatocellular carcinoma.

Authors:  Y Haruna; N Hayashi; T Kamada; P Hytiroglou; S N Thung; M A Gerber
Journal:  Cancer       Date:  1994-05-01       Impact factor: 6.860

9.  Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology.

Authors:  F Negro; D Pacchioni; Y Shimizu; R H Miller; G Bussolati; R H Purcell; F Bonino
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  Detection of hepatitis C virus (HCV) RNA in paraffin embedded tissue sections of human liver of non-A, non-B hepatitis patients by in situ hybridization.

Authors:  S Yamada; T Koji; M Nozawa; K Kiyosawa; P K Nakane
Journal:  J Clin Lab Anal       Date:  1992       Impact factor: 2.352
View more
  8 in total

1.  Immunogenicity of HGV NS5 protein expressed from Sf9 insect cells.

Authors:  H Ren; F L Zhu; S Y Zhu; Y Song; Z T Qi
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  A small yeast RNA inhibits HCV IRES mediated translation and inhibits replication of poliovirus in vivo.

Authors:  Xue-Song Liang; Jian-Qi Lian; Yong-Xing Zhou; Qing-He Nie; Chun-Qiu Hao
Journal:  World J Gastroenterol       Date:  2003-05       Impact factor: 5.742

Review 3.  RNA interference: antiviral weapon and beyond.

Authors:  Quan-Chu Wang; Qing-He Nie; Zhi-Hua Feng
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

4.  Detection of hepatitis C virus NS5 protein and genome in Chinese carcinoma of the extrahepatic bile duct and its significance.

Authors:  Ming-Yi Chen; Zhi-Qiang Huang; Le-Zhen Chen; Ya-Bing Gao; Rui-Yun Peng; De-Wen Wang
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

5.  Preparation of human single chain Fv antibody against hepatitis C virus E2 protein and its identification in immunohistochemistry.

Authors:  Yan-Wei Zhong; Jun Cheng; Gang Wang; Shuang-Shuang Shi; Li Li; Ling-Xia Zhang; Ju-Mei Chen
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

6.  Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

Authors:  Qing-He Nie; Yong-Qian Cheng; Yu-Mei Xie; Yong-Xing Zhou; Xian-Guang Bai; Yi-Zhan Cao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

7.  Construction of HCV-core gene vector and its expression in cholangiocarcinoma.

Authors:  Xiao-Fang Liu; Sheng-Quan Zou; Fa-Zu Qiu
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

8.  Expression of TIMP-1 and TIMP-2 in rats with hepatic fibrosis.

Authors:  Qing-He Nie; Guo-Rong Duan; Xin-Dong Luo; Yu-Mei Xie; Hong Luo; Yong-Xing Zhou; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.